Literature DB >> 221549

Alpha-1-antitrypsin deficiency and hepatocellular carcinoma.

J K Kelly, J S Davies, A W Jones.   

Abstract

Forty-two cases of hepatocellular carcinoma (HCC) were examined for the presence of the inclusions of alpha-1-antitrypsin (AAT), which indicate a carrier state for the Pi Z gene. These were found in the non-neoplastic liver tissue of two cases of HCC and in one of the 98 control livers, a difference that is not statistically significant. Typical globules of AAT deficiency were not found in HCC cells. One-quarter of HCCs, however, contained cells which showed diffuse cytoplasmic staining for AAT, a pattern seen also in the non-neoplastic livers.

Entities:  

Mesh:

Year:  1979        PMID: 221549      PMCID: PMC1145675          DOI: 10.1136/jcp.32.4.373

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Alpha1-antitrypsin, protein marker in oral contraceptive-associated hepatic tumors.

Authors:  P E Palmer; W M Christopherson; H J Wolfe
Journal:  Am J Clin Pathol       Date:  1977-12       Impact factor: 2.493

2.  Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson; I Hägerstrand
Journal:  Acta Med Scand       Date:  1974-06

3.  An electron microscopic study of giant cytosegresomes in acute liver injury due to heliotrine.

Authors:  J F Kerr
Journal:  Pathology       Date:  1969-04       Impact factor: 5.306

4.  Liver disease in adults with alpha-1 -antitrypsin deficiency.

Authors:  N O Berg; S Eriksson
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

5.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

6.  Alpha-antitrypsin deposition in primary hepatic carcinomas.

Authors:  P E Palmer; H J Wolfe
Journal:  Arch Pathol Lab Med       Date:  1976-05       Impact factor: 5.534

7.  Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Authors:  W K Blenkinsopp; G P Haffenden
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

8.  Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency.

Authors:  H W Gordon; J Dixon; J C Rogers; C Mittman; J Lieberman
Journal:  Hum Pathol       Date:  1972-09       Impact factor: 3.466

9.  Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association.

Authors:  T Morin; J P Martin; G Feldmann; B Rueff; J P Benhamou; C Ropartz
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

10.  alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis.

Authors:  D M Geddes; M Webley; D A Brewerton; C W Turton; M Turner-Warwick; A H Murphy; A M Ward
Journal:  Lancet       Date:  1977-11-19       Impact factor: 79.321

View more
  5 in total

1.  Hepatoma.

Authors: 
Journal:  West J Med       Date:  1980-06

2.  [Alpha 1-antitrypsin deficiency: a review with special reference to the significance of heterozygous deficiency].

Authors:  M Schneider; G Pott; U Gerlach
Journal:  Klin Wochenschr       Date:  1986-03-03

3.  Demonstration of alpha 1-antitrypsin in paraffin sections of hepatoma and cirrhosis.

Authors:  L Nakopoulou; G Theodoropoulos; L Kotsis; N Papacharalampous
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

4.  Alpha-1-antitrypsin and the liver: a routine immunohistological screen.

Authors:  J M Theaker; K A Fleming
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

5.  Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer.

Authors:  L Sparos; Y Tountas; C Chapuis-Cellier; G Theodoropoulos; D Trichopoulos
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.